Company Filing History:
2 out of 4 
2 out of 43 
1 out of 25 
Years Active: 2007-2021
Title: Matthias Wymann: Innovator in Pharmaceutical Chemistry
Introduction
Matthias Wymann is a notable inventor based in Bern, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic applications. With a total of five patents to his name, Wymann's work focuses on innovative solutions for treating disorders mediated by lipid kinases.
Latest Patents
Wymann's latest patents include the invention of difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines. These compounds are classified as phosphoinositide 3-kinase (PI3K), mammalian target of rapamycin (mTOR), and PI3K-related kinase (PIKKs) inhibitors. The compounds are characterized by a specific formula, wherein certain components are nitrogen or carbon-based, with the requirement that at least two of these components are nitrogen. These innovative compounds are designed to be effective either alone or in combination with other therapeutic agents for treating various disorders.
Career Highlights
Throughout his career, Matthias Wymann has worked with prominent organizations, including Piqur Therapeutics AG and Universität Basel. His experience in these institutions has allowed him to advance his research and contribute to the development of groundbreaking pharmaceutical solutions.
Collaborations
Wymann has collaborated with esteemed colleagues such as Vladimir C
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.